Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
2000 1
2001 2
2002 2
2003 1
2004 2
2005 2
2006 3
2007 4
2008 4
2009 3
2010 13
2011 6
2012 7
2013 4
2014 6
2015 3
2016 4
2017 2
2018 8
2019 4
2020 9
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

88 results
Results by year
Filters applied: . Clear all
Page 1
Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutation.
Meng P, Koopman B, Kok K, Ter Elst A, Schuuring E, van Kempen LC, Timens W, Hiltermann TJN, Groen HJM, van den Berg A, van der Wekken AJ. Meng P, et al. Among authors: van kempen lc. Lung Cancer. 2020 Aug;146:358-361. doi: 10.1016/j.lungcan.2020.05.036. Epub 2020 Jun 4. Lung Cancer. 2020. PMID: 32534795 Free article.
An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma.
Cook MG, Massi D, Szumera-Ciećkiewicz A, Van den Oord J, Blokx W, van Kempen LC, Balamurugan T, Bosisio F, Koljenović S, Portelli F, van Akkooi ACJ; EORTC Melanoma Group. Cook MG, et al. Among authors: van kempen lc. Eur J Cancer. 2019 Jun;114:1-7. doi: 10.1016/j.ejca.2019.03.010. Epub 2019 Apr 17. Eur J Cancer. 2019. PMID: 31005015
Comprehensive routine diagnostic screening to identify predictive mutations, gene amplifications, and microsatellite instability in FFPE tumor material.
Steeghs EMP, Kroeze LI, Tops BBJ, van Kempen LC, Ter Elst A, Kastner-van Raaij AWM, Hendriks-Cornelissen SJB, Hermsen MJW, Jansen EAM, Nederlof PM, Schuuring E, Ligtenberg MJL, Eijkelenboom A. Steeghs EMP, et al. Among authors: van kempen lc. BMC Cancer. 2020 Apr 7;20(1):291. doi: 10.1186/s12885-020-06785-6. BMC Cancer. 2020. PMID: 32264863 Free PMC article.
Angiosarcomatous transdifferentiation of metastatic melanoma.
Kilsdonk MJ, Romeijn TR, Kelder W, van Kempen LC, Diercks GF. Kilsdonk MJ, et al. Among authors: van kempen lc. J Cutan Pathol. 2020 Dec;47(12):1211-1214. doi: 10.1111/cup.13857. Epub 2020 Sep 28. J Cutan Pathol. 2020. PMID: 32865830 Free PMC article.
Molecular pathology of cutaneous melanoma.
van Kempen LC, Redpath M, Robert C, Spatz A. van Kempen LC, et al. Melanoma Manag. 2014 Nov;1(2):151-164. doi: 10.2217/mmt.14.23. Epub 2014 Dec 4. Melanoma Manag. 2014. PMID: 30190820 Free PMC article. Review.
Melanoma progression in a changing environment.
van Kempen LC, van Muijen GN, Ruiter DJ. van Kempen LC, et al. Eur J Cell Biol. 2007 Feb;86(2):65-7. doi: 10.1016/j.ejcb.2006.12.001. Epub 2007 Jan 22. Eur J Cell Biol. 2007. PMID: 17241688 Review. No abstract available.
ESP, EORTC, and EURACAN Expert Opinion: practical recommendations for the pathological diagnosis and clinical management of intermediate melanocytic tumors and rare related melanoma variants.
de la Fouchardiere A, Blokx W, van Kempen LC, Luzar B, Piperno-Neumann S, Puig S, Alos L, Calonje E, Massi D; ESP Dermatopathology Working Group; EORTC Melanoma Group; EURACAN. de la Fouchardiere A, et al. Among authors: van kempen lc. Virchows Arch. 2021 Jan 12. doi: 10.1007/s00428-020-03005-1. Online ahead of print. Virchows Arch. 2021. PMID: 33432480
Inflammation, proteases and cancer.
van Kempen LC, de Visser KE, Coussens LM. van Kempen LC, et al. Eur J Cancer. 2006 Apr;42(6):728-34. doi: 10.1016/j.ejca.2006.01.004. Epub 2006 Mar 9. Eur J Cancer. 2006. PMID: 16524717 Review.
88 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page